Cytokine Production and Signaling Pathways in Respiratory Virus Infection

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2013 Sep 25

PMID 24062733

Citations 31

Authors

Hirokazu Kimura

Masakazu Yoshizumi

Haruyuki Ishii

Kazunori Oishi

Akihide Ryo

Affiliations

Soon will be listed here.

Abstract

It has been confirmed that respiratory virus infections can induce abberant cytokine production in the host. These cytokines may be associated with both elimination of the virus and complications in the host, such as virus-induced asthma. Representative host defense mechanisms against pathogens, including bacteria and viruses, are mediated by the innate immune system. Cells of the innate immune system express essential molecules, namely pattern recognition receptors (PRRs), such as Toll-like receptors, nucleotide-binding oligomerization domain-like receptors, and retinoic acid-inducible gene-I-like receptors. These PRRs can recognize components of pathogens such as bacterial lipopolysaccharide, viral antigens, and their genomes (DNA and RNA). Furthermore, PRRs activate various signaling pathways resulting in cytokine production against pathogen infection. However, the exact mechanisms remain unknown. In this review, we mainly focus on the representative mechanisms of cytokine production through PRRs and signaling pathways due to virus infections, including respiratory virus infections. In addition, we describe the relationships between respiratory infections and virus-induced asthma.

Citing Articles

Immunoprofiles of COVID-19 uniquely differentiated from other viruses: A machine learning investigation of multiplex immunoassay data.

Kaur A, Krishnan V PNAS Nexus. 2024; 3(8):pgae327.

PMID: 39157461 PMC: 11327922. DOI: 10.1093/pnasnexus/pgae327.

Lipid Mediators and Cytokines/Chemokines Display Differential Profiles in Severe versus Mild/Moderate COVID-19 Patients.

Ravindran R, OConnor E, Gupta A, Luciw P, Khan A, Dorreh N Int J Mol Sci. 2023; 24(17).

PMID: 37685858 PMC: 10488250. DOI: 10.3390/ijms241713054.

Advances in the Relationship between Respiratory Viruses and Asthma.

Romero-Tapia S, Guzman Priego C, Del-Rio-Navarro B, Sanchez-Solis M J Clin Med. 2023; 12(17).

PMID: 37685567 PMC: 10488270. DOI: 10.3390/jcm12175501.

Gene Expression Profiles of the Immuno-Transcriptome in Equine Asthma.

Padoan E, Ferraresso S, Pegolo S, Barnini C, Castagnaro M, Bargelloni L Animals (Basel). 2023; 13(1).

PMID: 36611613 PMC: 9817691. DOI: 10.3390/ani13010004.

Rhinovirus Infection and Virus-Induced Asthma.

Hayashi Y, Sada M, Shirai T, Okayama K, Kimura R, Kondo M Viruses. 2022; 14(12).

PMID: 36560620 PMC: 9781665. DOI: 10.3390/v14122616.

References

Kato M, Tsukagoshi H, Yoshizumi M, Saitoh M, Kozawa K, Yamada Y . Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing. Pediatr Allergy Immunol. 2010; 22(1 Pt 2):e87-94. DOI: 10.1111/j.1399-3038.2010.01026.x. View

Yamaya M . Virus infection-induced bronchial asthma exacerbation. Pulm Med. 2012; 2012:834826. PMC: 3432542. DOI: 10.1155/2012/834826. View

Ishioka T, Kimura H, Kita H, Obuchi M, Hoshino H, Noda M . Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549). Cell Biol Int. 2010; 35(5):467-74. DOI: 10.1042/CBI20100255. View

Barbalat R, Ewald S, Mouchess M, Barton G . Nucleic acid recognition by the innate immune system. Annu Rev Immunol. 2011; 29:185-214. DOI: 10.1146/annurev-immunol-031210-101340. View

Klein Klouwenberg P, Tan L, Werkman W, van Bleek G, Coenjaerts F . The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit Rev Immunol. 2010; 29(6):531-50. DOI: 10.1615/critrevimmunol.v29.i6.40. View

Koetzler R, Zaheer R, Wiehler S, Holden N, Giembycz M, Proud D . Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells. J Allergy Clin Immunol. 2008; 123(1):201-208.e9. DOI: 10.1016/j.jaci.2008.09.041. View

Xu P, Lou J, Ren Y, Miao C, Deng X . Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome. J Infect. 2012; 65(5):380-91. DOI: 10.1016/j.jinf.2012.08.001. View

Pothlichet J, Meunier I, Davis B, Ting J, Skamene E, von Messling V . Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog. 2013; 9(4):e1003256. PMC: 3623797. DOI: 10.1371/journal.ppat.1003256. View

Ramos I, Fernandez-Sesma A . Innate immunity to H5N1 influenza viruses in humans. Viruses. 2013; 4(12):3363-88. PMC: 3528270. DOI: 10.3390/v4123363. View

10.

Picard C, Casanova J, Puel A . Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev. 2011; 24(3):490-7. PMC: 3131061. DOI: 10.1128/CMR.00001-11. View

11.

Salek-Ardakani S, Croft M . Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity. J Interferon Cytokine Res. 2010; 30(4):205-18. PMC: 3001890. DOI: 10.1089/jir.2010.0026. View

12.

Watanabe T, Yoshikawa H, Abe Y, Yamazaki S, Uehara Y, Abe T . Renal involvement in children with influenza A virus infection. Pediatr Nephrol. 2003; 18(6):541-4. DOI: 10.1007/s00467-003-1143-z. View

13.

Kumar H, Kawai T, Akira S . Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. DOI: 10.3109/08830185.2010.529976. View

14.

Kawai T, Akira S . Antiviral signaling through pattern recognition receptors. J Biochem. 2006; 141(2):137-45. DOI: 10.1093/jb/mvm032. View

15.

Loo Y, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L . Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2007; 82(1):335-45. PMC: 2224404. DOI: 10.1128/JVI.01080-07. View

16.

Melchjorsen J, Jensen S, Malmgaard L, Rasmussen S, Weber F, Bowie A . Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol. 2005; 79(20):12944-51. PMC: 1235860. DOI: 10.1128/JVI.79.20.12944-12951.2005. View

17.

Heymann P, Carper H, Murphy D, Platts-Mills T, Patrie J, McLaughlin A . Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004; 114(2):239-47. PMC: 7185400. DOI: 10.1016/j.jaci.2004.04.006. View

18.

Vandevenne P, Sadzot-Delvaux C, Piette J . Innate immune response and viral interference strategies developed by human herpesviruses. Biochem Pharmacol. 2010; 80(12):1955-72. DOI: 10.1016/j.bcp.2010.07.001. View

19.

Hofmann P, Sprenger H, Kaufmann A, Bender A, Hasse C, Nain M . Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol. 1997; 61(4):408-14. DOI: 10.1002/jlb.61.4.408. View

20.

He X, Greenberg H . CD8+ T-cell response against hepatitis C virus. Viral Immunol. 2002; 15(1):121-31. DOI: 10.1089/088282402317340279. View